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The European Council Directive 97/43/EURATOM introduce specific 
requirements aimed at the reduction of the probability and the 
magnitude of accidents in radiotherapy. Within a European 
Commission (EC) project, the implementation of these requirements 
in radiotherapy in Europe is reviewed through detailed web-based 
questionnaires, focusing on the national systems of risk management 
in external beam radiotherapy and the national systems for 
classification, recording and reporting of adverse events or near 
misses concerning patient safety in external beam radiotherapy. The 
results, together with a review of available international systems 
related to risk management, are used to prepare European guidelines 
on a risk analysis of accidental and unintended exposures in external 
beam radiotherapy.  
The results of the questionnaires reveals that more than half of the 
countries already implemented the legal basis for risk analysis and 
event’s classification, recording and reporting. However, the lack of 
this basis in many countries and the lack of practical implementation 
in most of the countries highlight the need for further European 
guidelines.   
The guidelines under preparation will review the available risk 
assessment methodologies, both general methodologies like Event 
Tree, Fault Tree and Process analysis including critical point, and 
methodologies dedicated to radiotherapy such as Failure Mode and 
Effects Analysis (FMEA) and Risk Matrix. The risk assessment 
methodologies vary as for their purpose and capabilities in different 
steps of the risk management: hazard and failure identification, 
events’ consequence, likelihood and severity evaluation, actions 
decision process and feedback analysis. The guidelines will discuss the 
value of the various methodologies and give advice and examples on 
their application in radiotherapy, aiming to establish a minimum 
approach dedicated to radiotherapy.  
Further, basic terminology for classification and reporting of adverse 
events and near misses is proposed. Common terminology facilitates 
the analysis and comparison of reported data from different sources 
and is a key to compare the risk of radiotherapy with other health 
care areas. Existing general healthcare taxonomies with specific codes 
for radiotherapy should be used as much as possible in order to 
integrate radiotherapy reporting in existing general healthcare 
reporting systems with an important save of resources.  The event 
reporting systems should preferably be called event learning systems, 
to emphasize that reporting is only one step in a process aimed at 
learning from events.  Departmental reporting/learning systems 
should be part of the safety culture and ideally, a module in 
radiotherapy information systems.  Monitoring is fundamental to 
demonstrate the implementation of remedial actions, to close the 
cycle of learning and improving safety after an event takes place.  
The risk management envisaged in the guidelines will significantly 
contribute to the improvement of patient safety in radiotherapy.  
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Purpose/Objective: Prostate cancer is predominantly a multifocal 
disease, which consists of an index lesion and one or more satellites. 
The success of focal radiation treatment relies primarily on how well 
prostate tumors can be delineated by using MR imaging. The 
sensitivity and specificity for tumor detection on multi-parametric MRI 
is highly reduced for tumors smaller than 5 mm in diameter.  
Focal therapy for prostate cancer can be delivered in different ways. 
Focal-only therapy will treat only the visible tumor and not the whole 
prostate. Focal boost therapy (e.g. FLAME study) will treat the whole 
prostate and boost visible tumor. The aim of this study was to analyze 
distances and volumes of satellites relative to the index lesion in 
order to investigate the potential of a CTV margin for use in focal 
therapy. 
Materials and Methods: A total of 61 patients who underwent a 
radical prostatectomy were included in this study. On the H&E stained 
slides retrieved from these specimens, the uro-pathologist contoured 
the index lesion and satellites. Then the slides were digitized and 
stacked with a 4 mm distance. The slide-stacks were imported in our 
in-house developed delineation program (WorldMatch) for further 
analysis. The distance between the borders of the delineated tumors 
was measured and volumes of all delineated tumors were calculated.  
Results: Of the 61 patients, 51 (84%) had multifocal disease. The 
median number of satellites in all patients was 3. In 50% of the 
patients, the distance of the index lesion to the satellites was 1.0 cm 
or more, with a maximum of 4.4 cm. 
32% of the satellites were smaller than 5 mm in diameter. Of the total 
tumor volume 14% was located in the satellites. However, the 
contribution of satellites smaller than 5 mm to the total tumor volume 
only amounted to an average of 0.9%. 
If all tumors larger than 5 mm were assumed to be GTV, 54% of the 
patients did not have any tumor volume outside of the GTV. 
  
Conclusions: A CTV margin around the index lesion which contains all 
satellites will cover in the majority of patients nearly the entire 
prostate. The limited contribution of satellites smaller than 5 mm to 
the overall tumor load however raises the question as to their clinical 
relevance. If the small satellites are of no/little clinical relevance and 
the GTV for focal therapy includes all tumors ≥ 5 mm in diameter, 
than focal-only therapy to the GTV may be safe. If however small 
satellites are clinically relevant, treatment of the entire prostate is 
necessary with possibly a focal boost to the GTV. 
In both cases, careful screening to identify larger satellites is 
warranted. 
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Purpose/Objective: To compare the 3-dimensional intra-fraction 
variations of prostate position within the pelvis with whole-pelvic 
fixed-field intensity-modulated radiation therapy (IMRT) vs. intensity-
modulated arc therapy (IMAT) in high-risk prostate cancer (PCa). 
Materials and Methods: Fifteen PCa patients underwent whole pelvic 
radiotherapy using either dynamic IMRT with a sliding window 
technique (n= 8) or IMAT (n= 7). All the patients had a kV cone-beam 
computed tomography (CBCT) before and immediately after each 
fraction of IMRT or IMAT. 
Intra-fraction motions of the prostate were determined using a 2-step 
procedure performed on each pre- and post-treatment imaging: 1) 
